Two Sigma Investments
SCMP

Two Sigma Investments’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Two Sigma Investments’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-548,672
Closed -$9.85M – 3788
2017
Q4 		$9.85M Buy
548,672
+499,409
+1,014% +$6.15M 0.03% 613
2017
Q3 		$581K Buy
+49,263
New +$553K ﹤0.01% 2057
2016
Q2 		– Sell
-12,714
Closed -$139K – 3430
2016
Q1 		$139K Sell
12,714
-56,021
-82% -$708K ﹤0.01% 2652
2015
Q4 		$1.19M Buy
68,735
+6,669
+11% +$120K 0.01% 1392
2015
Q3 		$1.23M Sell
62,066
-477
-0.8% -$10.9K 0.01% 1080
2015
Q2 		$1.03M Sell
62,543
-18,035
-22% -$313K ﹤0.01% 1636
2015
Q1 		$1.25M Sell
80,578
-85,884
-52% -$1.33M 0.01% 1444
2014
Q4 		$2.38M Buy
166,462
+132,954
+397% +$1.4M 0.01% 957
2014
Q3 		$218K Sell
33,508
-21,424
-39% -$142K ﹤0.01% 1576
2014
Q2 		$379K Buy
+54,932
New +$388K ﹤0.01% 1743
2014
Q1 		– Sell
-15,279
Closed -$144K – 2430
2013
Q4 		$144K Buy
+15,279
New +$109K ﹤0.01% 2047

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Two Sigma Investments's SCMP Position: Q1 2018 in Review

Two Sigma Investments sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 548,672 shares — an estimated $9.85M sold.

Two Sigma Investments first reported a position in SCMP in Q4 2013 and held it in 11 quarters. The position peaked at $9.85M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Two Sigma Investments reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Investments sold 548,672 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $9.85M.
  • Two Sigma Investments first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 11 quarters.
  • Two Sigma Investments's Sucampo Pharmaceuticals, Inc. position peaked at $9.85M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.